Diabetes specialist nurses can provide practical demonstrations and personalised rotation strategies during routine appointments
Five GLP-1RAs are available in Australia (dulaglutide, exenatide BD, exenatide QW, liraglutide, and lixisenatide), one is undergoing regulatory approval (semaglutide), and three are currently available under the governments reimbursement scheme (dulaglutide, exenatide BD, and exenatide QW)
In a primary semaglutide study, researchers found that the co-formulated semaglutide/SNAC tablet was absorbed through the stomach in an area close to the tablet surface
Today I will show you a drug class that works
It is FDA-approved for Type 2 diabetes, chronic weight management, and the reduction of major adverse cardiovascular events in adults with Type 2 diabetes and established cardiovascular disease
Overall results were positive for both arms, with the PAP plus GLP-1 arm showing a 62.8% apnea-hypopnea index (AHI) reduction compared to a 55.0% AHI reduction from GLP-1 treatment alone